| scholarly article | Q13442814 |
| P50 | author | Erdal Eren | Q57548456 |
| P2093 | author name string | Bumin Nuri Dündar | |
| Nihal Dündar | |||
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| Insulin detemir: from concept to clinical experience | Q36382590 | ||
| An update on the long-acting insulin analogue glargine | Q36546691 | ||
| Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial | Q36575356 | ||
| Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus | Q37288770 | ||
| Insulin analogues: an example of applied medical science | Q37361417 | ||
| Intensive treatment of type 1 diabetes | Q40846310 | ||
| Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia | Q42594982 | ||
| Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes | Q42611726 | ||
| Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp | Q45281574 | ||
| Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial | Q46286325 | ||
| Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus | Q46511255 | ||
| Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes | Q46673041 | ||
| Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes. | Q46709594 | ||
| Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes | Q46790310 | ||
| Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICT | Q47294978 | ||
| Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. | Q51480799 | ||
| Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes | Q57413008 | ||
| Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study | Q57951497 | ||
| Albumin binding and time action of acylated insulins in various species | Q71237607 | ||
| Reference body mass index curves for Turkish children 6 to 18 years of age | Q79616931 | ||
| Insulin therapy regimens in paediatric age | Q80131738 | ||
| At last, a weight neutral insulin? | Q80442190 | ||
| Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis | Q81317578 | ||
| Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial | Q81906445 | ||
| P433 | issue | 4 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| insulin detemir | Q410965 | ||
| insulin glargine | Q417317 | ||
| teenager | Q1492760 | ||
| NPH insulin | Q1929845 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 181-187 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Journal of clinical research in pediatric endocrinology | Q26842313 |
| P1476 | title | Comparison of the efficacy and safety of insulin glargine and insulin detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus receiving intensive insulin therapy | |
| P478 | volume | 1 |
| Q35570360 | Insulin detemir in a twice daily insulin regimen versus a three times daily insulin regimen in the treatment of type 1 diabetes in children: A pilot randomized controlled trial | cites work | P2860 |
Search more.